Saturday 7 November 2026 Export LXRX’s income statement to Excel — free account

Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $49.8 million, up 60.2% from fiscal 2024.

Revenue: −20.7%
EPS: +21.3%
Free cash flow: +66.1%
Total debt: −8.17%

Quarter to September 2026, against a year earlier

1.79 0.18 +11.18%

Follow LXRX

Alert me

Market cap: $716.4M
P/E: 0.0×
Fwd P/E: −8.4×
Dividend yield: —
F-score: 4/9
Altman Z: −12.11
Beneish M: −1.17
Dividend safety: n/a

Overview

	Sep '26 From the 10-Q filed 5 Nov	Jun '26	Mar '26	Dec '25	Older periods
ROE Full definition →	(43.91%)	(40.21%)	(16.01%)	(39.72%)	+8 more TTM periods Free account
Piotroski F-Score Full definition →	2	2	4	4
ROA Full definition →	(27.84%)	(25.70%)	(9.21%)	(20.83%)
ROIC Full definition →	(109.13%)	(96.36%)	(18.49%)	(46.81%)
Return on Tangible Assets Full definition →	(36.12%)	(33.30%)	(14.67%)	(60.73%)
Average Days of Receivables Full definition →	16.83	14.46	61.73	17.47
Free Cash Flow per Share Full definition →	(0.11)	(0.15)	(0.10)	(0.19)
Free Cash Flow Full definition →	(49.23)	(64.99)	(38.80)	(67.85)
Other line items
Cash ROIC Full definition →	(12.34%)	(15.60%)	(9.17%)	(26.32%)
Accounts Receivable Turnover Full definition →	18.75	21.68	2.35	17.01
Accounts Payable Turnover Full definition →	0.11	0.09	0.05	0.03
Inventory Turnover Full definition →	0.63	0.52	1.48	1.07
Average Days of Payables Full definition →	3,628.63	2,388.81	3,106.65	4,106.92
Days of Inventory on Hand Full definition →	1,030.89	1,219.39	286.19	374.32
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	149.77%	145.34%	84.11%	122.73%
Selling, General and Administrative Expense of Revenue Full definition →	96.54%	85.23%	50.18%	74.93%
Share Based Compensation of Revenue Full definition →	32.78%	30.61%	18.02%	25.13%
Interest Coverage Full definition →	(7.72)	(6.50)	(2.99)	(5.87)
Operating CF/Net income Full definition →	0.79	1.06	1.49	1.35
Depreciation/Fixed assets Full definition →	1.66	1.57	1.45	1.25
Capex/Depreciation Full definition →	0.00	0.00	0.00	0.00
Revenue per Share Full definition →	0.09	0.09	0.17	0.14
Operating CF per Share Full definition →	(0.11)	(0.15)	(0.10)	(0.19)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly